{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:43:56Z","timestamp":1789533836940,"version":"build-2803163510"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0198334","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T13:48:03Z","timestamp":1527860883000},"page":"e0198334","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants"],"prefix":"10.1371","volume":"13","author":[{"given":"Marine","family":"Perrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"D\u00e9sir\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Storto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Todesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Bertine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Le Hingrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Visseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Calvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Genevi\u00e8ve","family":"Marcelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6441-7054","authenticated-orcid":true,"given":"Charlotte","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"ref1","unstructured":"France, Minist\u00e8re des affaires sociales et de la sant\u00e9 (2012- \u2026), Morlat P. Prise en charge m\u00e9dicale des personnes vivant avec le VIH Rapport 2013: recommandations du groupe d\u2019experts. Paris: DILA\u2014Direction de l\u2019information l\u00e9gale et administrative: La documentation fran\u00e7aise; 2013."},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011345","article-title":"Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing","volume":"5","author":"C Hedskog","year":"2010","journal-title":"PLoS ONE"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/365671a0","article-title":"Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing","volume":"365","author":"BA Larder","year":"1993","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/1469-0691.12056","article-title":"Next-generation sequencing technology in clinical virology","volume":"19","author":"MR Capobianchi","year":"2013","journal-title":"Clinical Microbiology and Infection"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1128\/JVI.06541-11","article-title":"Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen","volume":"86","author":"R Fisher","year":"2012","journal-title":"Journal of Virology"},{"key":"ref6","article-title":"Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations","author":"E Todesco","year":"2017","journal-title":"HIV Medicine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/596736","article-title":"Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes","volume":"199","author":"BB Simen","year":"2009","journal-title":"Journal of Infectious Diseases"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1371\/journal.pmed.0050158","article-title":"Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-na\u00efve populations and associate with reduced treatment efficacy","volume":"5","author":"JA Johnson","year":"2008","journal-title":"PLoS Medicine"},{"key":"ref9","unstructured":"NGuyen, Fofana DB, L\u00ea MP, Charpentier C, Peytavin G, Wirden M, Lambert-Niclot S, et al. Prevalence and clinical impact of minority resistant variants to integrase inhibitors. Conference on Retroviruses and Opportunistic Infections. 2018; Abstract 545"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/jac\/dku557","article-title":"Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing","volume":"70","author":"E Todesco","year":"2015","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref11","article-title":"Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen","author":"S Raymond","year":"2017","journal-title":"Clinical Infectious Diseases"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e10952","DOI":"10.1371\/journal.pone.0010952","article-title":"Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-na\u00efve subjects in the CASTLE study","volume":"5","author":"M Lataillade","year":"2010","journal-title":"PloS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"19752","DOI":"10.7448\/IAS.17.4.19752","article-title":"Analysis of transmitted HIV-1 drug resistance using 454 ultra-deep-sequencing and the DeepChek(\u00ae<\/sup>)-HIV system","volume":"17","author":"A Garcia-Diaz","year":"2014","journal-title":"Journal of the International AIDS Society"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1093\/infdis\/jix397","article-title":"Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance","volume":"216","author":"M Noguera-Julian","journal-title":"Journal of Infectious Diseases.017"},{"key":"ref15","first-page":"359","article-title":"Susceptibility of HIV-1 isolates to zidovudine: correlation between widely applicable culture test and PCR analysis","volume":"5","author":"M Jung","year":"1992","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1128\/JCM.01516-12","article-title":"Universal Amplification, Next-Generation Sequencing, and Assembly of HIV-1 Genomes","volume":"50","author":"A Gall","year":"2012","journal-title":"Journal of Clinical Microbiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","article-title":"Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data","volume":"28","author":"M Kearse","year":"2012","journal-title":"Bioinformatics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"JM Bland","year":"1986","journal-title":"Lancet"},{"key":"ref19","unstructured":"R Core Team. R: A language and environment for statistical computing. 2015; Available: http:\/\/www.R-project.org\/<\/ext-link>"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/aid.2015.0201","article-title":"Evaluation of automatic analysis of ultradeep pyrosequencing raw data to determine percentages of HIV resistance mutations in patients followed-up in hospital","volume":"32","author":"P Bellecave","year":"2016","journal-title":"AIDS Research and Human Retroviruses"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e36494","DOI":"10.1371\/journal.pone.0036494","article-title":"Low-cost ultra-wide genotyping using Roche\/454 pyrosequencing for surveillance of HIV drug resistance","volume":"7","author":"DM Dudley","year":"2012","journal-title":"PloS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1101\/gr.6468307","article-title":"Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance","volume":"17","author":"C Wang","year":"2007","journal-title":"Genome Research"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2164-12-245","article-title":"Accuracy and quality assessment of 454 GS-FLX Titanium pyrosequencing","volume":"12","author":"A Gilles","year":"2011","journal-title":"BMC Genomics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/gb-2007-8-7-r143","article-title":"Accuracy and quality of massively parallel DNA pyrosequencing","volume":"8","author":"SM Huse","year":"2007","journal-title":"Genome Biology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e98740","DOI":"10.1371\/journal.pone.0098740","article-title":"Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-na\u00efve subjects in Hunan Province, China","volume":"9","author":"Z Xiaobai","year":"2014","journal-title":"PloS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e6079","DOI":"10.1371\/journal.pone.0006079","article-title":"Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use","volume":"4","author":"T Le","year":"2009","journal-title":"PloS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAD.0b013e3283427dcb","article-title":"Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy","volume":"25","author":"DD Goodman","year":"2011","journal-title":"AIDS"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0198334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T01:15:37Z","timestamp":1540343737000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0198334"}},"subtitle":[],"editor":[{"given":"Nicolas","family":"Sluis-Cremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0198334","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}